Lv11
20 积分 2022-10-10 加入
L -Proline-Stabilized Human IgG: Privigen ® 10% for Intravenous Use and Hizentra ® 20% for Subcutaneous Use
1分钟前
已关闭
The Evolution of Commercial Antibody Formulations
2小时前
已完结
Osmolality of Excipients for Parenteral Formulation Measured by Freezing Point Depression and Vapor Pressure – A Comparative Analysis
2小时前
已完结
Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract
2小时前
已关闭
Formulation and Evaluation of Multidose Propofol Nanoemulsion Using Statistically Designed Experiments
13天前
已完结
The mechanism of action of MF59 – An innately attractive adjuvant formulation
23天前
已完结
Formulation and stabilization of recombinant protein based virus-like particle vaccines
25天前
已完结
Physicochemical and functional characterization of vaccine antigens and adjuvants
25天前
已完结
Antigen-Adjuvant Interactions in Vaccines by Taylor Dispersion Analysis: Size Characterization and Binding Parameters
25天前
已完结
Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics
1个月前
已完结